SG Americas Securities’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-28,959
| Closed | -$341K | – | 2793 |
|
|
2019
Q2 | $341K | Buy |
+28,959
| New | +$341K | ﹤0.01% | 1846 |
|
|
2018
Q3 | – | Sell |
-6,781
| Closed | -$107K | – | 3021 |
|
|
2018
Q2 | $107K | Buy |
+6,781
| New | +$107K | ﹤0.01% | 2639 |
|
|
2018
Q1 | – | Sell |
-11,561
| Closed | -$132K | – | 3009 |
|
|
2017
Q4 | $132K | Buy |
+11,561
| New | +$132K | ﹤0.01% | 2272 |
|
|
2017
Q3 | – | Sell |
-15,580
| Closed | -$178K | – | 3238 |
|
|
2017
Q2 | $178K | Buy |
15,580
+8,140
| +109% | +$93K | ﹤0.01% | 2216 |
|
|
2017
Q1 | $155K | Sell |
7,440
-14,323
| -66% | -$298K | ﹤0.01% | 2338 |
|
|
2016
Q4 | $453K | Buy |
21,763
+18,516
| +570% | +$385K | ﹤0.01% | 1580 |
|
|
2016
Q3 | $106K | Buy |
+3,247
| New | +$106K | ﹤0.01% | 2691 |
|
|
2016
Q2 | – | Sell |
-7,323
| Closed | -$179K | – | 2633 |
|
|
2016
Q1 | $179K | Buy |
+7,323
| New | +$179K | ﹤0.01% | 1995 |
|
|
2015
Q4 | – | Sell |
-7,481
| Closed | -$245K | – | 2579 |
|
|
2015
Q3 | $245K | Buy |
+7,481
| New | +$245K | ﹤0.01% | 1326 |
|
|
2015
Q2 | – | Sell |
-4,255
| Closed | -$123K | – | 2422 |
|
|
2015
Q1 | $123K | Sell |
4,255
-124
| -3% | -$3.58K | ﹤0.01% | 1865 |
|
|
2014
Q4 | $127K | Buy |
+4,379
| New | +$127K | ﹤0.01% | 2470 |
|